Published in J Altern Complement Med on August 01, 2001
Use of complementary and alternative medical therapies among racial and ethnic minority adults: results from the 2002 National Health Interview Survey. J Natl Med Assoc (2005) 2.56
'They don't ask me so I don't tell them': patient-clinician communication about traditional, complementary, and alternative medicine. Ann Fam Med (2009) 1.83
Patient Disclosure about Herb and Supplement Use among Adults in the US. Evid Based Complement Alternat Med (2007) 1.23
Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I. Regulation and quality. Br J Clin Pharmacol (2003) 1.12
Complementary and alternative medicine (CAM) use by African American (AA) and Caucasian American (CA) older adults in a rural setting: a descriptive, comparative study. BMC Complement Altern Med (2003) 1.06
Ethnic differences in the use of complementary and alternative therapies among adults with osteoarthritis. Prev Chronic Dis (2006) 1.01
Use of dietary supplements by female seniors in a large Northern California health plan. BMC Geriatr (2005) 0.95
A multivariate test of an expanded Andersen Health Care utilization model for complementary and alternative medicine (CAM) use in African Americans. J Altern Complement Med (2009) 0.93
Collaborative Care for Older Adults with low back pain by family medicine physicians and doctors of chiropractic (COCOA): study protocol for a randomized controlled trial. Trials (2013) 0.88
Phytochemical Assays of Commercial Botanical Dietary Supplements. Evid Based Complement Alternat Med (2004) 0.88
A systematic review of the prevalence of herb usage among racial/ethnic minorities in the United States. J Immigr Minor Health (2013) 0.85
Negotiating complementary and alternative medicine use in primary care visits with older patients. Patient Educ Couns (2012) 0.82
Effects of complementary therapy on health in a national U.S. sample of older adults. J Altern Complement Med (2010) 0.82
Physician-patient communication about dietary supplements. Patient Educ Couns (2013) 0.81
What patients think doctors know: beliefs about provider knowledge as barriers to safe medication use. Patient Educ Couns (2013) 0.81
Attitudes of older adults regarding disclosure of complementary therapy use to physicians. J Appl Gerontol (2013) 0.79
Complementary and alternative therapies for urinary symptoms: use in a diverse population sample qualitative study. Urol Nurs (2012) 0.78
Disclosure of Traditional and Complementary Medicine Use and Its Associated Factors to Medical Doctor in Primary Care Clinics in Kuching Division, Sarawak, Malaysia. Evid Based Complement Alternat Med (2017) 0.75
Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ (2000) 7.36
Infection in organ-transplant recipients. N Engl J Med (1998) 6.49
Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2001) 3.74
Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis. J Immunol (1981) 3.71
Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts. N Engl J Med (1981) 3.63
Conceptual data model for a central patient database. Proc Annu Symp Comput Appl Med Care (1991) 3.29
The antisense homology box: a new motif within proteins that encodes biologically active peptides. Nat Med (1995) 2.79
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis (1997) 2.78
1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens (1999) 2.72
Genetic determination of iso-cytochromes c in yeast. J Mol Biol (1965) 2.56
The structural gene for yeast cytochrome C. Proc Natl Acad Sci U S A (1966) 2.56
Clinical, microbiologic and therapeutic aspects of purulent pericarditis. Am J Med (1975) 2.46
Infective endocarditis--1973. Prog Cardiovasc Dis (1974) 2.42
Efficacy of single-dose and conventional amoxicillin therapy in urinary-tract infection localized by the antibody-coated bacteria technic. N Engl J Med (1978) 2.33
Phenotypic and genotypic characterization of nosocomial Staphylococcus aureus isolates from trauma patients. J Clin Microbiol (1998) 2.22
Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation (1981) 2.22
Hepatic abscess: changes in clinical, bacteriologic and therapeutic aspects. Am J Med (1974) 2.21
Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli. Infect Immun (1989) 2.12
NADPH- and NADH-nitrate reductases from soybean leaves. Arch Biochem Biophys (1976) 2.09
The release of four mediators of immediate hypersensitivity from human leukemic basophils. J Immunol (1975) 1.92
Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med (1990) 1.92
Experimental Observations ON THE ANTISEPTIC ACTION OF HYPOCHLOROUS ACID AND ITS APPLICATION TO WOUND TREATMENT. Br Med J (1915) 1.87
Studies in muscle activity: II. The influence of speed on the mechanical efficiency. J Physiol (1924) 1.84
Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. N Engl J Med (1979) 1.83
Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med (1981) 1.77
BK virus in solid organ transplant recipients: an emerging syndrome. Transplantation (2001) 1.75
Imaging focal sites of bacterial infection in rats with indium-111-labeled chemotactic peptide analogs. J Nucl Med (1991) 1.65
Smoking cessation treatment for patients with schizophrenia. Am J Psychiatry (1998) 1.64
Does measurement instrument moderate the association between the serotonin transporter gene and anxiety-related personality traits? A meta-analysis. Mol Psychiatry (2005) 1.62
Laparoscopic repair of giant paraesophageal hernia: 100 consecutive cases. Ann Surg (2000) 1.55
Pharmacokinetics of 18F-labeled fluconazole in healthy human subjects by positron emission tomography. Antimicrob Agents Chemother (1993) 1.55
Salvage of lower extremities following combined orthopedic and vascular trauma. A predictive salvage index. Am Surg (1987) 1.55
A patient and relative centred evaluation of treatment escalation plans: a replacement for the do-not-resuscitate process. J Med Ethics (2010) 1.50
Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis. Clinical and serologic features and response to antiviral chemotherapy. Ann Intern Med (1986) 1.48
The pattern of gene expression in human CD34(+) stem/progenitor cells. Proc Natl Acad Sci U S A (2001) 1.45
Adverse reactions to duck embryo rabies vaccine. Range and incidence. Ann Intern Med (1973) 1.44
A retrospective review over 1999 to 2007 of head, shoulder and knee soft tissue and fracture dislocation injuries and associated costs for rugby league in New Zealand. Int J Sports Med (2011) 1.43
Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies. J Clin Oncol (2000) 1.43
Single-dose amoxicillin therapy for urinary tract infection. Multicenter trial using antibody-coated bacteria localization technique. JAMA (1980) 1.43
Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients. Transplantation (1977) 1.40
Estimation of fetal lung volume using enhanced 3-dimensional ultrasound: a new method and first result. Br J Obstet Gynaecol (1996) 1.40
The therapeutic prescription for the transplant patient. Transpl Infect Dis (2002) 1.39
In search of the hot appendix--a clinician's view of inflammation imaging. J Nucl Med (1990) 1.38
Neurologic complications of bacterial endocarditis. Medicine (Baltimore) (1978) 1.36
Long-term outcome in patients registered with tuberculosis in Zomba, Malawi: mortality at 7 years according to initial HIV status and type of TB. Int J Tuberc Lung Dis (2004) 1.35
Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology (1995) 1.35
Cytomegalovirus antigenemia: clinical correlations in transplant recipients and in persons with AIDS. J Clin Microbiol (1993) 1.33
Endogenous endophthalmitis: 10-year experience at a tertiary referral centre. Eye (Lond) (2010) 1.29
Random errors in the measurement of 10 cardiovascular risk factors. Eur J Epidemiol (2001) 1.29
Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation. Transplantation (1985) 1.29
Central nervous system infection in the chronically immunosuppressed. Medicine (Baltimore) (1982) 1.27
Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1993) 1.27
Production of a low molecular weight eosinophil polymorphonuclear leukocyte chemotactic factor by anaplastic squamous cell carcinomas of human lung. J Clin Invest (1978) 1.26
Infection in the renal transplant recipient. Am J Med (1981) 1.25
Vascular smooth muscle caldesmon. J Biol Chem (1986) 1.24
A case of human rabies in Kansas: epidemiologic, clinical, and laboratory considerations. J Infect Dis (1970) 1.24
Antidepressant prescribing to Hispanic and non-Hispanic white patients in primary care. Ann Pharmacother (2001) 1.24
Association of herpesvirus infections with T-lymphocyte-subset alterations, glomerulopathy, and opportunistic infections after renal transplantation. N Engl J Med (1983) 1.23
Cytomegalovirus prophylaxis in solid organ transplant recipients. Transplantation (1996) 1.22
Single-dose therapy with trimethoprim-sulfamethoxazole for urinary tract infection in women. Rev Infect Dis (1982) 1.21
The pattern of gene expression in human CD15+ myeloid progenitor cells. Proc Natl Acad Sci U S A (2001) 1.21
Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection. Transplantation (1984) 1.20
Detection of arboviral RNA directly from mosquito homogenates by reverse-transcription-polymerase chain reaction. J Virol Methods (2001) 1.19
Effects of interferon-alpha on cytomegalovirus reactivation syndromes in renal-transplant recipients. N Engl J Med (1983) 1.18
Effects of antithymocyte globulin on cytomegalovirus infection in renal transplant recipients. Transplantation (1981) 1.18
Hepatitis C virus and organ transplantation. Transplantation (1996) 1.17
Accumulation of immunoglobulin G at focal sites of inflammation. Eur J Nucl Med (1992) 1.17
Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3. Transplantation (1992) 1.16
A hybrid human and machine resource curation pipeline for the Neuroscience Information Framework. Database (Oxford) (2012) 1.16
Defective human mononuclear leukocyte chemotaxis as an index of host resistance to malignant melanoma. Clin Immunol Immunopathol (1976) 1.15
Closure of the Thurso veterinary investigation centre. Vet Rec (2001) 1.15
Physician-patient communication about over-the-counter medications. Soc Sci Med (2001) 1.15
The spectrum of Salmonella infection. Infect Dis Clin North Am (1988) 1.13
A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery. Acta Orthop Scand (2000) 1.13
A 16S rDNA-based PCR method for rapid and specific detection of Clostridium perfringens in food. Mol Cell Probes (1994) 1.12
From the National Institutes of Health. Summary of a workshop on cytomegalovirus infections during organ transplantation. J Infect Dis (1979) 1.11
Structure and copy number of gene clusters related to the pap P-adhesin operon of uropathogenic Escherichia coli. Infect Immun (1989) 1.09
Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial. Ann Intern Med (1995) 1.09
Primary cytomegalovirus infection following cardiac transplantation in a murine model. Transplantation (1984) 1.09
Emesis and diarrhea induced by enterotoxin of Clostridium perfringens type A in monkeys. Can J Microbiol (1971) 1.09
Palliative radiotherapy improves pain and reduces functional interference in patients with painful bone metastases: a quality assurance study. Clin Oncol (R Coll Radiol) (2006) 1.08
Trimethoprim-sulfamethoxazole. N Engl J Med (1980) 1.08
Regional perfusion, oxygen metabolism, blood volume and immunoglobulin G accumulation at focal sites of infection in rabbits. Eur J Nucl Med (1992) 1.08
The circadian rhythm in photosynthesis in Acetabularia in the presence of actinomycin D, puromycin, and chloramphenicol. J Gen Physiol (1967) 1.07
Invasive aspergillus infection: possible non-ward common source within the hospital environment. J Hosp Infect (1989) 1.07
Preemptive therapy in immunocompromised hosts. N Engl J Med (1991) 1.07
Amoxicillin and potassium clavulanate: an antibiotic combination. Mechanism of action, pharmacokinetics, antimicrobial spectrum, clinical efficacy and adverse effects. Pharmacotherapy (1984) 1.06
Mortality after hip fracture: regional variations in New Zealand. N Z Med J (1999) 1.04
The effect of infection on T lymphocyte subpopulations: a preliminary report. Int J Immunopharmacol (1981) 1.04
Neurologic complications following the treatment of human Babesia microti infection with diminazene aceturate. Am J Trop Med Hyg (1979) 1.04
Biodistribution and dosimetry of technetium-99m-hydrazino nicotinamide IgG: comparison with indium-111-DTPA-IgG. J Nucl Med (1996) 1.04
Report of the Committee on School Health Program. Am J Public Health (N Y) (1922) 1.04
Motor vehicle driver injury and socioeconomic status: a cohort study with prospective and retrospective driver injuries. J Epidemiol Community Health (2003) 1.04
Role of cardiac output in the pressor responses to graded muscle ischemia in man. J Appl Physiol Respir Environ Exerc Physiol (1978) 1.04
The impact of cyclosporine therapy on the occurrence of infection in the renal transplant recipient. Transplant Proc (1986) 1.03
'Toxic strep syndrome' associated with group C Streptococcus. Arch Intern Med (1992) 1.03